Middle East and Africa In-Vitro Diagnosis & Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers MEA In-Vitro Diagnosis & Treatment Market Analysis and it is segmented by By Technique (Histochemistry, Molecular Diagnostics, Hematology, Self-blood Glucose Testing, Immunochemistry, Other Techniques), Product (Instrument, Reagent, Other Products), Usability (Disposable IVD Device, Reusable IVD Device), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Other Applications) End User (Diagnostic Laboratories, Hospitals and Clinics, Other End Users) Diagnostic Approach (Point-of-Care Diagnostics, Centralized Laboratory-based Diagnostics) and Geography (GCC, South Africa, Rest of Middle East & Africa). The Values are Provided in Terms of USD Million for above segments

Middle East and Africa In-Vitro Diagnosis & Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Middle East and Africa In-Vitro Diagnosis & Treatment Industry Overview

The Middle East and Africa In-Vitro Diagnostics market is competitive and consists of several major players. In terms of market share, a few of the major players currently dominate the market in the GCC. Some of the major players in the market are Abbott Laboratories, BioMerieux SA, Sysmex Corporation, F. Hoffmann-La Roche AG, and Becton, Dickinson, and Company, among others. The companies mostly monitor distribution via their branch offices or distributors operating at the domestic and international levels.

Middle East and Africa In-Vitro Diagnosis & Treatment Market Leaders

  1. Abbott Laboratories

  2. F. Hoffmann-La Roche AG

  3. Becton, Dickinson and Company

  4. Sysmex Corporation

  5. BioMerieux SA

  6. *Disclaimer: Major Players sorted in no particular order
Middle East and Africa In-Vitro Diagnostics Market Concentration